American Century Companies Inc Rigel Pharmaceuticals Inc Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$0.67 - $11.9 $119 - $2,118
-178 Reduced 1.14%
15,501 $23,000
Q3 2022

Nov 14, 2022
SELL
$1.1 - $12.2 $283 - $3,147
-258 Reduced 1.62%
15,679 $19,000
Q2 2022

Aug 12, 2022
BUY
$0.67 - $3.19 $10,677 - $50,839
15,937 New
15,937 $18,000
Q4 2021

Feb 07, 2022
SELL
$2.36 - $3.57 $519,820 - $786,338
-220,263 Closed
0 $0
Q3 2021

Nov 10, 2021
BUY
$3.5 - $4.5 $770,920 - $991,183
220,263 New
220,263 $800,000

Others Institutions Holding RIGL

# of Institutions
8
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.96B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email